Cargando…

Sodium-Glucose Cotransporter-2 Inhibitor Immediately Decreases Serum Uric Acid Levels in Type 2 Diabetic Patients

BACKGROUND: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are new antihyperglycemic drugs for type 2 diabetes. SGLT2 inhibitors ameliorate cardiovascular morbidity and mortality as well as kidney disease progression by reducing body weight (BW), blood pressure (BP), visceral adiposity, albuminur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohashi, Naro, Aoki, Taro, Matsuyama, Takashi, Ishigaki, Sayaka, Isobe, Shinsuke, Fujikura, Tomoyuki, Hashimoto, Takuya, Tsuriya, Daisuke, Morita, Hiroshi, Kato, Akihiko, Yasuda, Hideo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537479/ https://www.ncbi.nlm.nih.gov/pubmed/33004785 http://dx.doi.org/10.12659/MSM.926086

Ejemplares similares

Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease
por: Ishigaki, Sayaka, et al.
Publicado: (2021)

Salt intake causes B-type natriuretic peptide elevation independently of blood pressure elevation in the general population without hypertension and heart disease
por: Ohashi, Naro, et al.
Publicado: (2021)

Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation
por: Aoki, Taro, et al.
Publicado: (2020)

The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules
por: Ohashi, Naro, et al.
Publicado: (2019)

Salt Loading Aggravates the Relationship between Melatonin and Proteinuria in Patients with Chronic Kidney Disease
por: Ohashi, Naro, et al.
Publicado: (2019)

The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function
por: Matsuyama, Takashi, et al.
Publicado: (2018)

The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors
por: Ohashi, Naro, et al.
Publicado: (2018)

Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan
por: Iwakura, Takamasa, et al.
Publicado: (2022)

Case report: increased single-nephron estimated glomerular filtration rate in an adult patient with low birth weight
por: Shiozaki, Yuriko, et al.
Publicado: (2020)

Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases
por: Iwakura, Takamasa, et al.
Publicado: (2021)

Regular exercise and branched‐chain amino acids prevent ischemic acute kidney injury‐related muscle wasting in mice
por: Nagata, Soichiro, et al.
Publicado: (2020)

Plasma Soluble (Pro)renin Receptor Reflects Renal Damage
por: Ohashi, Naro, et al.
Publicado: (2016)

A case report of thin basement membrane nephropathy accompanied by sporadic glomerulocystic kidney disease
por: Hashimoto, Hiroyuki, et al.
Publicado: (2019)

The Effects of Unilateral Nephrectomy on Blood Pressure and Its Circadian Rhythm
por: Ohashi, Naro, et al.
Publicado: (2016)

A high ratio of G1 to G0 phase cells and an accumulation of G1 phase cells before S phase progression after injurious stimuli in the proximal tubule
por: Iwakura, Takamasa, et al.
Publicado: (2014)

Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels
por: Ohashi, Naro, et al.
Publicado: (2014)

Cytoresistance after acute kidney injury is limited to the recovery period of proximal tubule integrity and possibly involves Hippo‐YAP signaling
por: Iwakura, Takamasa, et al.
Publicado: (2017)

A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome
por: Ono, Masafumi, et al.
Publicado: (2018)

The Sequential Development of Antiglomerular Basement Membrane Nephritis and Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Ohashi, Naro, et al.
Publicado: (2017)

Decline in Walking Independence and Related Factors in Hospitalization for Dialysis Initiation: A Retrospective Cohort Study
por: Hirano, Yuma, et al.
Publicado: (2022)

Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease
por: Ohashi, Naro, et al.
Publicado: (2012)

Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy
por: Iwakura, Takamasa, et al.
Publicado: (2015)

The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
por: Dong, Meiyuan, et al.
Publicado: (2023)

MDM2 inhibitor ameliorates cisplatin‐induced nephropathy via NFκΒ signal inhibition
por: Fujikura, Tomoyuki, et al.
Publicado: (2018)

Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action
por: Kochanowska, Anna, et al.
Publicado: (2023)

Sodium-Glucose Cotransporter-2 (SGLT-2) Attenuates Serum Uric Acid (SUA) Level in Patients with Type 2 Diabetes
por: Hussain, Mazhar, et al.
Publicado: (2021)

Hyponatremia in a patient with scleroderma renal crisis: a potential role of activated renin-angiotensin system
por: Fukasawa, Hirotaka, et al.
Publicado: (2012)

A Comparison of Systemic Inflammation-Based Prognostic Scores in Patients on Regular Hemodialysis
por: Kato, Akihiko, et al.
Publicado: (2013)

Impacts of Sodium/Glucose Cotransporter-2 Inhibitors on Circulating Uric Acid Concentrations: A Systematic Review and Meta-Analysis
por: Akbari, Abolfazl, et al.
Publicado: (2022)

G-protein-coupled receptor 40 agonist GW9508 potentiates glucose-stimulated insulin secretion through activation of protein kinase Cα and ε in INS-1 cells
por: Hashimoto, Takuya, et al.
Publicado: (2019)

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial( )
por: Doehner, Wolfram, et al.
Publicado: (2022)

Acquired Fanconi syndrome in patients with Legionella pneumonia
por: Kinoshita-Katahashi, Naoko, et al.
Publicado: (2013)

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium‐Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus
por: Chino, Yukihiro, et al.
Publicado: (2021)

Case of human immunodeficiency virus infection presenting as a tip variant of focal segmental glomerulosclerosis: A case report and review of the literature
por: Goto, Daiki, et al.
Publicado: (2018)

Detailed Causality between Sodium-glucose Cotransporter 2 Inhibitor and Tubulointerstitial Nephritis
por: Morita, Hiroyasu, et al.
Publicado: (2022)

Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients
por: Ichikawa, Hitomi, et al.
Publicado: (2016)

Effects of sodium glucose cotransporter-2 inhibitors on serum uric acid in type 2 diabetes mellitus: A systematic review with an indirect comparison meta-analysis
por: Xin, Yakai, et al.
Publicado: (2019)

Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study
por: Fukasawa, Hirotaka, et al.
Publicado: (2014)

Roles of the Skp2/p27 axis in the progression of chronic nephropathy
por: Suzuki, Sayuri, et al.
Publicado: (2012)

A Case with Significant Proteinuria Caused by Secreted Protein from Urothelial Carcinoma
por: Sakakima, Masanori, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0hd2cu7jv2ojdeeire5j2a7veb